SVA vs BIIB: Which Stock is Better?
Side-by-side comparison of Sinovac Biotech Ltd and Biogen Inc in 2026
SVA
Sinovac Biotech Ltd
$6.47
BIIB
Biogen Inc
$176.02
Key Metrics Comparison
| Metric | SVA | BIIB | Winner |
|---|---|---|---|
| Market Cap | $642.44M | $25.83B | BIIB |
| P/E Ratio | 6.66 | 20.05 | SVA |
| EPS (TTM) | $0.97 | $8.78 | BIIB |
| Revenue Growth | 3.0% | -0.1% | SVA |
| Gross Margin | 86.8% | 78.9% | SVA |
Analyze SVA
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SVA or BIIB a better investment?
Comparing SVA and BIIB: Sinovac Biotech Ltd has a market cap of $642.44M while Biogen Inc has $25.83B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SVA and BIIB?
SVA (Sinovac Biotech Ltd) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SVA or BIIB?
Based on P/E ratios, SVA trades at a lower multiple (6.7x vs 20.0x).
Which is growing faster: SVA or BIIB?
SVA has higher revenue growth at 3.0% vs -0.1% for BIIB.
Which company is more profitable: SVA or BIIB?
Sinovac Biotech Ltd (SVA) has higher gross margins at 86.8% compared to 78.9% for BIIB.
Which is the larger company: SVA or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $25.83B compared to $642.44M for SVA.
Should I buy SVA or BIIB in 2026?
Both SVA and BIIB have investment merit. SVA trades at $6.47 while BIIB trades at $176.02. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SVA and BIIB stock?
Key differences: Market Cap ($642.44M vs $25.83B), P/E Ratio (6.7x vs 20.0x), Revenue Growth (3.0% vs -0.1%), Gross Margin (86.8% vs 78.9%).